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Abstract
We have previously shown that regulatory T cells (Tregs) infiltrating follicular lymphoma
lymph nodes are quantitatively and qualitatively different than those infiltrating normal and
reactive nodes. To gain insight into how such Treg populations differ, we performed RNA
sequence (RNAseq) analyses on flow sorted Tregs from all three sources. We identify sev-
eral molecules that could contribute to the observed increased suppressive capacity of fol-
licular lymphoma nodal tregs, including upregulation of CTLA-4, IL-10, and GITR, all
confirmed by protein expression. In addition, we identify, and confirm functionally, a novel
mechanism by which Tregs target to and accumulate within a human tumor microenviron-
ment, through the down regulation of S1PR1, SELL (L-selectin) and CCR7, potentially
resulting in greater lymph node retention. In addition we identify and confirm functionally the
upregulation of the chemokine receptor CXCR5 as well as the secretion of the chemokines
CXCL13 and IL-16 demonstrating the unique ability of the follicular derived Tregs to localize
and accumulate within not only the malignant lymph node, but also localize and accumulate
within the malignant B cell follicle itself. Such findings offer significant new insights into how
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follicular lymphoma nodal Tregs may contribute to the biology of follicular lymphoma and
identify several novel therapeutic targets.
Introduction
Follicular lymphoma is the second most common type of non-Hodgkin’s lymphoma and
despite its indolent nature, it is essentially incurable.[1] Gene expression and immuno-histo-
chemistry studies suggest that immune microenvironment is a critical determinant of the natu-
ral history of this disease showing strong correlation between number, type and anatomical
location of immune-effector cells in pre-treatment patient biopsies with treatment outcome.
[2–7] Regulatory T cells (Tregs), a CD4+ T helper cell population that suppresses both CD4+
and CD8+ cell priming and effector function, and normal germinal center (GC) B cell prolifera-
tion and antibody production has emerged as one such critical immune-effector cell population
having prognostic significance.[2, 3, 8, 9] We and others have shown that the proportion of
CD4+ T-cells infiltrating FL lymph nodes (FL) with a Treg phenotype is greater than that seen
in normal lymph nodes (NLN).[10]
FL Tregs potently inhibit FL effector CD4+ and CD8+ T cell proliferation and cytokine pro-
duction and appear to have greater suppressor function than that of Tregs infiltrating NLN, as
we have shown.[10] The mechanisms of such suppression are mediated partly by TGF-beta,
adenosine, and PD-1/PD-1L interactions.[10–14] It would thus be anticipated that FL Tregs
would inhibit any endogenous anti-tumor effector T cell responses or those elicited by immu-
notherapy with or without chemotherapy. If so, increased number of Tregs should be associ-
ated with worse outcome as is seen with many, but not all solid tumors, however there are
conflicting data regarding prognostic significance of Tregs in FL.[2, 3, 5, 7, 15–18] These poten-
tial contradictory effects of Tregs on clinical outcome is likely due to the balance of Tregs in the
microenvironment relative to other immune-effector cells, and the type and anatomical distri-
bution of the Tregs dictating their net biological activity.
Tregs have been shown to up-regulate the canonical transcription factor of the specific T-
cell populations they suppress in response to unique microenvironmental signals.[8, 19–21]
This results in their expression of a chemokine receptor profile that drives these Tregs to traffic
to and suppress their target T cell population. For example, Tregs that express T-bet up-regu-
late CXCR3 driving them to traffic to sites of Th1 inflammation and thus suppress Th1 cells.
Similarly, Tregs that localize in the GC are a distinct subset of Tregs called T-follicular regula-
tory cells (TFR).[8, 22–25] Such cells modulate the B-cell GC response by limiting the number
and function of T-follicular helper (TFH) cells. In mice, TFR are derived from naïve Tregs that
up-regulate Bcl-6 upon activation, resulting in CXCR5 expression directing such cells to the
GC via gradients of CXCL13.[8, 24, 25] We and others have shown an increased proportion of
TFR in FL compared to that seen in NLN and in contrast to observations in mice, we have
shown that human FL TFR are partially derived from TFH.[26] TFH cells support the viability
of FL B-cells.[22] In addition, the TFH-B-cell axis is a critical pathway in the biology of several
types of cancer.[27–31] Taken together, Tregs that inhibit tumor specific TH1 cells would be
expected to have different effects on tumor growth than Tregs that inhibit TFH cells in tumors,
where these cells play a tumor supporting role. Therefore, molecular events that modulate Treg
migration and trafficking would be anticipated to partly dictate whether Tregs have a tumor
suppressive and/or promoting role.
Although Tregs play a fundamental role in FL biology, significant questions remain regard-
ing how such Tregs infiltrating FL differ from those infiltrating NLN, especially for homing,
migration and function. To this end, we performed RNAseq analysis of purified Tregs from
Treg Homing and Retention in Follicular Lymphoma
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malignant FL. As we had the unique ability to obtain NLN, we performed RNAseq on their
sorted Tregs. Finally, we also performed RNAseq on Tregs from pathologically enlarged reac-
tive lymph nodes (RLN), biopsies of which showed reactive lymphoid hyperplasia as seen with
infectious or inflammatory processes.
The following gene, protein and functional studies resulted in several key findings: 1) many
differentially expressed genes in FL vs. NLN are related to cell migration and movement, 2) FL
Tregs have the unique ability to localize within the malignant B-cell follicle, in part through an
autocrine CXCL13-CXCR5 axis, 3) production and secretion of IL-16 by FL Tregs as well as
increased retention of Tregs in the FL resulting from irreversible down-regulation of S1P1 may
partly account for observed increased frequency of Tregs in FL relative to NLN, 4) FL Tregs
may modulate tumor microenvironment through their elicitation of IL-16 and CCL4, and 5)
Several molecules, including CTLA-4, IL-10 and GITR may comprise a pattern that could
account for the increased suppressive capacity of FL Tregs.
Methods
Patient Samples
Primary FL and RLN were obtained from, 12 and 5 patients respectively, undergoing routine
biopsy (Table D in S1 File). NLN were obtained from 10 different patients undergoing vascular
surgery where obstructive LNs are removed. Single cell suspensions (SCSs) were prepared as
previously described.[10, 32] Primary samples were acquired under a University of Rochester
Institutional Review Board approved protocol and written consent was obtained.
Flow Cytometry and Cell Sorting
Cryopreserved SCSs were thawed (one freeze/thaw cycle), washed once in FACS buffer (PBS,
1% heat-inactivated FBS), stained with surface antibodies, washed with FACS buffer. Stained
cells were fix/permeabilzed and stained with intracellular antibodies using the human Treg
(FoxP3) staining kit (eBioscience, San Diego, CA). Stained samples were analyzed on a 18 color
LSR-II Flow Cytometer (BD Biosciences, San Jose, CA); data analysis using FlowJo version
8.7.3 software (FlowJo, Ashland, OR). See Supplemental Methods in S1 File for analytical pan-
els. Tregs were sorted using the following markers PI-CD3+CD4+CD25+CD127- on an 18 color
FACS Aria-II cell sorter and FACS Diva software (version 7.0; BD Biosciences, San Jose, CA;
Fig D, part A in S1 File). The sorted Tregs were at least 95% pure and (98% FoxP3+ when
stained for FoxP3; Fig D in S1 File). FOXP3mRNA levels were consistently high in all samples
further confirming that the flow sorted cells were purified Tregs (Fig E in S1 File).
RNA Isolation
Total RNA was extracted from sorted Treg cells using AllPrep DNA/RNAMicro Kit (Qiagen,
Valencia CA) following manufacture’s protocol. RNA quality was assessed by a 2100 BioAnaly-
zer (Agilent Technologies, Santa Clara CA) at the University of Rochester Genomic Research
Center. Total RNA from each sample was used for cDNA synthesis using the Ovation1
RNA-Seq, with normalized RNA input for each sample (NuGEN, San Carlos CA). Amplified
cDNA product was purified through a MinElute reaction cleanup column (Qiagen). Amplified
cDNA quality was determined with a 2100 BioAnalyzer (Agilent Technologies).
Quantitative Real-Time Polymerase Chain Reaction
Taqman assays for quantification of mRNA for BCL6, CCL20, CCL3, CCR6, CCR7, CXCR4,
FOXP3, IL-10 KLF2, S1PR1, SELL and ACTB (beta-actin) were obtained from the Assays on
Treg Homing and Retention in Follicular Lymphoma
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Demand Panel (Life Technologies, Carlsbad CA). All reactions were performed in triplicate
with 40 cycles and analyzed on ABI 7900HT real-time PCR instruments (Applied Biosystems,
Carlsbad CA) by the Genomics Research Center using ΔΔCt relative quantification method.
RNAseq Data
Raw sequences were generated using a SOLiD 4 System (Applied Biosystems). 50bp reads were
output and demultiplexed according to barcode using SOLiD Instrument Control Software.
The resulting sequence reads were aligned to the reference genome (hg19) using Bioscope Soft-
ware (Applied Biosystems) with default settings. Data were expressed as reads per million
mapped reads (RPM). RNAseq data described in this publication have been deposited in
NCBI’s Gene Expression Omnibus (GEO) and are available through GEO Series accession
number GSE74102 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74102).
Cytokine Analysis
Sorted Tregs (Fig D, part B in S1 File) were cultured at 37°C/5% CO2 in serum free media stim-
ulated with soluble anti-CD3 (OKT3) and anti-CD28 (CD28.2) monoclonal Abs (1 μg/ml;
eBioscience) for 6 hours. Culture supernatants were analyzed at the Roswell Park Cancer Insti-
tute Flow & Image Cytometry Facility (Buffalo NY) for IL-10, MIP-1α (CCL3), MIP-1β
(CCL4) (MILLIPLEX MAP Human High Sensitivity T cell Panel, EMDMillipore, Billerica
MA), BCA-1 (CXCL13) and IL-16 (MILLIPLEX MAP Human Cytokine/Chemokine Magnetic
Bead Panel II, EMDMillipore) on a Luminex 100 analyzer (Luminex, Austin TX). Analysis
performed in duplicate.
Cell Migration Assay
SCSs were depleted of dead cells using the Dead Cell Removal Kit (Miltenyi Biotech, Bergisch
Gladbach Germany) followed by human CD4 T cell isolation by negative magnetic selection
using the Human CD4+ T cell Isolation (Miltenyi Biotech). CD4 T cells were cultured at 37°C/
5% CO2 in RPMI 1640 medium containing 10% FBS overnight. Transwell chemotaxis assays
were performed using 24-well plates with 5-μm pore size inserts (Corning, Tewksbury MA).
Cells were equilibrated at 37°C/5% CO2 in migration medium (RPMI 1640, 1% BSA, 10 mM
HEPES, 1% pen-strep/L-glutamine) at 1 × 106 cells/ml for 1h before use. A total of 500 μl che-
moattractant in migration medium was applied to the lower chamber and 200 μl cells applied
to the upper chamber. Chemokines used were 1000 ng/ml CXCL13 and 25ng/ml SDF-1α
(PeproTech, Rocky Hill NJ) and 1nM D-erythro-S1P (Avanti Polar Lipids, Alabaster AL).
After 2 h at 37°C/5% CO2, inserts were discarded and cells from the lower chamber including
input samples were stained with CD3, CD4, CD25 and CD127 Abs. Each sample had 50 μl
Accucount beads (5.1-μm diameter; Spherotech, Lake Forest IL) added before analysis for
quantitation by flow cytometry. Percent migration was determined as 100 × ([Tregs in lower
chamber/bead events in lower chamber]/[input Treg events/input bead events]) and then the
% baseline migration to media only was subtracted. Duplicate samples were run.
Statistics and Expression Analysis
Significant differences for flow, Luminex, and qPCR data were assessed using Wilcoxon rank
sum tests with permutations to compute p-values. Data from the migration assay were ana-
lyzed using paired t-tests after applying a log transformation to normalize data. Only genes
that had an RPM value> 3 for at least one sample were retained in subsequent analyses
(n = 14725). Resulting expression measurements were log-transformed after adding “1” to
Treg Homing and Retention in Follicular Lymphoma
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values. Associated group comparison p-values were computed using 10,000 permutations.
Genes were selected using false discovery rate (FDR) with a threshold of 0.05 for NLN vs. FL
and RLN vs. FL, and 0.10 for RLN vs. NLN. Clustering, heat map generation, principal compo-
nents and other analyses were performed using scripts written in Matlab (The Mathworks Inc.,
Natick MA, www.mathworks.com). Functional enrichment, pathway and upstream regulator
analyses were performed with Ingenuity Pathway Analysis (IPA, Qiagen, Redwood City CA,
www.ingenuity.com).
Results
Gene Expression Differences between FL, RLN, and NLN Tregs
We found 820 genes out of 14725 that were significantly differentially expressed in at least one
comparison (FL vs. NLN, RLN vs FL, and RLN vs. NLN). Fig 1A illustrates the relationship
between unadjusted p-value and fold change for all genes in the FL vs. NLN comparison (Fig A
in S1 File shows all comparisons). We found 497 genes differentially expressed in FL vs. NLN,
with most of them being down-regulated (293 lower in FL, 204 higher; 191 and 142, respec-
tively, having greater than 2-fold change) with FDR< 0.05. In contrast, a majority of differen-
tially expressed genes were up-regulated in RLN vs. NLN (164 total: 108 higher in RLN, 56
lower with FDR< 0.10; no genes selected at FDR< 0.05). Most differentially expressed genes
were higher in RLN relative to FL at FDR< 0.05 (274 total: 254 higher in RLN, 20 lower).
Fig 1B shows the first three principal components (PC) for all 27 samples, as projections of
the 3-D data onto the three bivariate planes to visualize group differences. Fig 1C shows a simi-
lar plot only considering 820 selected genes described above. Both plots indicate separation
between groups, even when PCs were computed with all genes. In that case, separation of the
sample groups was observed between NLN and FL, notably along PC3 (Fig 1B) indicating dis-
tinct transcriptional profile-wide differences. Fig 1D shows a heat map for the 820 genes where
samples are clustered within each group, suggesting that the largest separation was found
between FL and NLN samples. RLN samples differed to a lesser extent from both FL and NLN
samples, while also exhibiting commonalities in gene expression with both of these two groups.
Fig 1E shows overlap in significant gene lists along with relationships in directions of
changes of genes. 44 genes that were significant in both the FL vs. NLN and RLN vs. NLN com-
parisons, changed in the same directions (relative to NLN). Remarkably, the only gene com-
mon to all three lists was S1PR1 where expression in NLN> RLN> FL (Fig 1E).
Alterations in Lymphocyte Trafficking and Nodal Retention
Table A in S1 File shows the top 25 significant up- and top 25 significant down-regulated genes
based on FDR. In FL vs. NLN, 6 of the 25 down-regulated genes are known to be involved in
lymphocyte migration and trafficking. No such genes were identified in either of the other two
comparisons. Noteworthy genes include S1PR1, the receptor for sphingosine-1-phosphate
(S1P), an extracellular lipid mediator critical for lymph node T cell egress, L-selectin (SELL), a
lymphocyte homing receptor that facilitates T-cell migration from the periphery into second-
ary lymph node structures, and chemokine receptor 7 (CCR7) which controls the migration of
T cells into inflamed tissues and the nodal T cell zone.
Functional Annotation Differences Correlating with Migration and Cell
Cycle
Fig 2A shows enriched functional annotations (from significant gene lists). Rows represent
annotations enriched at a Benjamini-Hochberg corrected p-value of less than 0.00001 for at
Treg Homing and Retention in Follicular Lymphoma
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Fig 1. Significant genes between groups and feature selection. A. Volcano plot for FL vs. NLN comparison. -log10 p-
value is plotted against the fold change (log2 scale). Black horizontal line corresponds to an FDR of 0.05. 37 genes with a
FDR < 0.001 (horizontal red and blue lines) and a greater than two-fold change in either direction are labeled. Red and blue
numbers indicate number of genes with FDR < 0.05 and a two-fold change. See Supplemental Fig 2 for similar plots of RLN
vs. NLN and RLN vs. FL. B. Distribution of 27 samples over the first three principal components (PCs). PCs were computed
Treg Homing and Retention in Follicular Lymphoma
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least one comparison. Notably, FL vs. NLN genes were enriched for cancer and migration cate-
gories while there was almost no representation of those for RLN vs. FL. Similarly, RLN vs. FL
genes showed enrichment for cell cycle categories while there was almost no enrichment in the
FL vs. NLN list. No enriched functions were found for RLN vs. NLN. This marked difference
in enriched functional annotation is consistent with relatively small overlap between these two
gene lists (Fig 1E). Results for IPA canonical pathways and upstream regulators analyses are
shown in Table B in S1 File and Fig B in S1 File.
Alterations in Lymphocyte Trafficking, Nodal Retention and Suppressive
Capacity
We compiled lists of genes in 14 migration related categories (Table 1) motivated by enrich-
ment of "cell migration" annotations, and by the significant down-regulation of S1PR1 and L-
selectin, both in FL vs. NLN Tregs. As we have previously shown that FL Tregs are more potent
suppressors than those derived from NLN,[10] we included genes that encoded for proteins
mediating Treg suppression. Gene expression differences of the categories’member genes as
shown in Fig 2B. Most of these genes were significant for FL vs. NLN at FDR< 0.1 or 0.05,
whereas a minority were significant for the other comparisons.
Expression of 21 differentially expressed genes related to Treg subsets, homing, retention
and immune cell recruitment as well as suppressive capacity is shown in Fig 3. FL has more
Tregs that express genes consistent with T-follicular regulatory cells (TFR), CD3+CD4+-
CXCR5+PD1+CD25+BCL6+FoxP3+, a population recently characterized in the FL microenvi-
ronment that suppress the function of TFH.[8, 22–26] Whereas NLN Tregs had variable
expression of RORC, there was essentially no RORC expression in FL Tregs. As RORC-
expressing Tregs produce IL-17,[33] this suggests that in contrast to NLN, there are no IL-17
producing Tregs in the FL microenvironment. Furthermore, our RNAseq results also support
published data[10, 34–41] suggesting that FL Tregs are more suppressive than NLN Tregs with
increased expression of CTLA4, IL-10, and GITR. Expression of both CD39 (ENTDP1) and
CD73 were reduced in FL derived Tregs as compared to NLN.
CCR7 was down-regulated in FL Tregs relative to NLN suggesting that FL Tregs are less
likely to reside in the T cell zone of the lymph node. CXCR5 is up-regulated at the transcrip-
tional level (consistent with TFR phenotype) compared to NLN Tregs which facilitates migra-
tion of these cells to the GC in response to a CXCL13 gradient within the GC. Additionally, FL
Tregs express CXCL13 suggesting the existence of an autocrine feedback resulting in Treg
retention in the GC. Finally, there is a striking decrease of S1PR1 in FL Tregs compared to
NLN Tregs. These results suggest, along with the nodal egress of T cells from S1PR1 binding to
its cognate ligand S1P, the transcription profile of FL Tregs favors the localization and reten-
tion of Tregs into the GC of the malignant lymph node. Finally, FL Treg retention is also sup-
ported by the finding that L-selectin (SELL) expression in FL Tregs is lower than that of NLN
Tregs.
using log10-transformed RPM to reduce the dimensionality. PCs were based on all 14725 genes. Shadows of three-
dimensional data are shown on the three coordinate planes. C. PCs computed considering only 820 selected genes. These
genes were significant for at least one pairwise comparison (FL vs. NLN, n = 497; RLN vs. FL, n = 274; RLN vs. NLN,
n = 164). D. Heat map of clustered, significant genes as described in C. Rows are genes, columns are samples, and color
maps to a gene’s z-score based on log-transformed data (computed independently for each gene). Samples are organized
by histology but are clustered within their group. Euclidean distance and average linkage were used for clustering. E.
Comparison of three statistical gene lists. Each bar represents a comparison with their constituent genes ranked according
to fold change (color) and with the number of up- and down-regulated genes shown in the red and blue portions,
respectively. Lines connecting bars represent genes shared between lists. (RL vs. FL is shown twice but with different
polarities). Only one gene, S1PR1 appeared in all three lists (highlighted in brown).
doi:10.1371/journal.pone.0155347.g001
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To validate RNAseq data we performed qPCR analysis of 11 of the 820 significant genes
(Table C in S1 File). Five of these that were found differentially expressed in FL vs. NLN based
on the RNAseq data remained significantly differentially expressed by qPCR (p 0.033), and
followed the same trend; those that did not reach statistical significance changed in the same
direction as in the RNAseq data.
Fig 2. Characteristics of significant gene lists and functionally relevant genes. A. IPA enriched functions for significant genes
for the three pairwise comparisons. Functions that had a B-H corrected enrichment p-value less than 0.00001 for at least one
comparison are shown. Functions were clustered to aid in visualization based on their patterns of category membership (a function
can be associated with or more broader category) using one minus the kappa statistic for distance (dendrogram not shown). In the
heat map, functions within each cluster (delineated by white lines) are sorted by size, their significance in the FL vs. NLN gene list,
and then the significance in the RLN vs. FL gene list. No enriched functions were found at this significance level for the RLN vs. NLN
list at this level of significance (middle column). B. Heat map of genes in categories from Table 1 that had a pairwise difference with
FDR < 0.1 for at least one comparison. Color maps to a gene’s z-score based on log-transformed data (computed independently for
each gene). Genes and samples (within groups) are clustered using Euclidean distance and average linkage. Circles next to the heat
map indicate whether the gene had a FDR < 0.1 (unfilled) or < 0.05 (filled) for the specified comparison.
doi:10.1371/journal.pone.0155347.g002
Treg Homing and Retention in Follicular Lymphoma
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Protein Expression Highlights Alterations in Lymphocyte Trafficking,
Nodal Retention and Suppressive Capacity
Fig 4 shows protein expression of several genes by flow cytometry in FL and NLN Treg com-
bined with corresponding gene expression data, some of which is shown in Fig 3. All cell sur-
face markers tested (CCR6, CCR7, CTLA4, CXCR5 and TNFRSF18) as well as the
transcription factors (BCL6 and RORC) were statistically significant in both RNAseq and flow
data (Fig 4A). However most of the intracellular cytokines, except for IL-10, were not signifi-
cantly different between FL and NLN Tregs at the protein level (Fig 4B). Furthermore, based
on multiplex immuno-assays, CCL4, IL-16 and CXCL13 are secreted at significantly higher lev-
els in FL vs. NLN Tregs (Fig 5). CCL3 and IL-10 follow the same trend, though not significant,
which may be partially due to low number of NLN Tregs. Together, these results validate the
RNAseq data at the protein level.
Fig 6 provides functional evidence that transcriptional differences of FL Tregs are related to
their migration to and retention in the lymph node follicle by showing that FL Tregs migrate
significantly more than NLN Tregs to CXCL13 (CXCR5 ligand) and that they were completely
unresponsive to S1P (S1PR1 ligand), the latter suggesting that their egress from the lymph
node will also be significantly impaired. As a positive control, migration to SDF1α is
unchanged in FL relative to NLN Tregs, demonstrating that these Tregs do not exhibit global
alteration in their ability to migrate to a common chemoattractant.
To understand whether down-regulation of S1PR1 in FL Tregs is reversible when separated
from their microenvironment, Tregs from four different FL samples were sorted and cultured
for up to 48h in complete media. Using RT-PCR, expression of S1PR1 did not change even at
48h (Fig C in S1 File).
Discussion
Although expression level of FOXP3 does not differ significantly between Tregs infiltrating FL,
NLN and RLN, differences in the global transcriptome profile exist between these populations,
Table 1. Gene list categories.
Gene List Name Total RNAseq FL vs NLN RLN vs NLN RLN vs FL
B7/CD28 Family 15 13 0 2 1
Cadherins 118 53 0 0 0
Constitutively Expressed Treg Antigens 3 3 1 0 0
Cytokines, Chemokines and their Receptors 228 152 11 5 1
Ig Superfamily Cell Adhesion Molecules 66 45 2 1 0
Integrins 27 23 4 0 0
Mediators of Treg Suppression 59 39 4 2 1
Other Co-Stimulatory Molecules 106 94 6 4 2
Reg. of T Cell Co-Stimulation by TNF Superfamily Members 23 18 1 1 0
SLAM Family 11 10 0 0 0
Selectins 11 10 2 0 1
Syndecans 6 4 0 0 0
Treg Homing and Retention 8 8 6 1 2
Treg Subsets 6 6 2 1 0
For each of 14 categories, the number of: total number of genes, number of genes expressed in our RNAseq data, and genes that are significant at
FDR < 0.05 (for FL vs. NLN and RLN vs. FL) or FDR < 0.1 (for RLN vs. NLN).
doi:10.1371/journal.pone.0155347.t001
Treg Homing and Retention in Follicular Lymphoma
PLOSONE | DOI:10.1371/journal.pone.0155347 May 26, 2016 9 / 18
Fig 3. Gene expression scatter plots of selected genes by category.RPM data are not log-transformed for these plots.
Line segments are group means. A. Treg subset genes. B. Treg homing and retention genes. C. Immune cell recruitment
genes.
doi:10.1371/journal.pone.0155347.g003
Treg Homing and Retention in Follicular Lymphoma
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Fig 4. Comparison of gene and protein expression for selected genes. Two-dimensional box-plots are shown
for NLN (black) and FL (red) for gene expression data (not log-transformed, x-axis) and flow cytometry data
(frequencies, y-axis). White circles represent the median values, thick lines represent the range between the 25th
and 75th percentiles, and thinner lines show the extent of the non-outlier data. Outliers are dots and are defined as
points at least 1.5 times the interquartile range beyond either the 25th or 75th percentiles. For gene expression
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mostly between FL and NLN. Further, we found that cell migration and movement categories
were highly enriched based on the FL vs. NLN comparison. Consistent with this, significant
differences were found in chemokine, chemokine and G-protein receptors, and adhesion mole-
cule genes in FL vs. NLN Tregs, including CXCL13, CCR7, CXCR5, S1P1 and L-selectin. These
differences suggest a propensity for GC localization and nodal retention of FL Tregs (Fig 7).
Our data support the novel finding that FL Tregs have the ability to “auto-regulate” their own
chemotaxis via a CXCL13-CXCR5 autocrine loop.
Previously, we found a greater proportion of T-cells having a Treg phenotype in FL com-
pared to NLN partially due to FL tumor cell elaboration of CCL22 which is chemotactic for
CCR4 expressing Treg-cells.[14] Present data suggest an additional novel mechanism, namely,
the lack of expression of S1P1 in FL but not NLN Tregs, a type 1 G-protein coupled receptor
that is a primary determinant for lymphocyte egress from the lymph node. S1P1 mediates lym-
phocyte egress from the thymus and secondary lymphoid organs likely through internalization
of the receptor upon agonist stimulation.[42] Because there is no optimal antibody to charac-
terize human S1P1 expression at the protein level, we confirmed our findings functionally by
demonstrating that Tregs from six different human FL samples were not able to migrate in
response to S1P, unlike in NLN. Although recently shown to mediate Treg accumulation in a
murine breast cancer model,[43] this is the first demonstration to our knowledge that S1P1
loss may be a mechanism for Treg accumulation in human tumor.
Microenvironmental signals may transiently alter expression patterns and functional capac-
ity of infiltrating lymphocytes, and removal from this environment may support reversion to
normal patterns. Local signals may account for the decrease in S1P1 expression, thus tempo-
rally retaining these cells within the tumor microenvironment. However, the decrease in S1P1
data, n = 10 (NLN) and n = 12 (FL). For flow cytometry data, n = 10 for both NLN and FL. Gene expression data
and flow cytometry data are from different sample sets, except for four NLN samples in common. Significant
differences in gene expression are based on FDR (see Methods).
doi:10.1371/journal.pone.0155347.g004
Fig 5. FL Tregs secrete significantly higher levels of selected cytokines and chemokines than NLN
Tregs. Tregs were sorted from FL (n = 10) and NLN (n = 5) samples and were cultured for six hours in serum
free media with added antiCD3/CD28. Culture supernatants were collected and analysed for IL-10, IL-16, CCL3,
CCL4, and CXCL13 by luminex. Assays were performed in duplicates. Line segments represent mean values
for each group. Values below the limit of detection are set to “0”. Significance indicated by asterisks (p < 0.05)
determined byWilcoxon rank sum tests with permutations to compute p-values.
doi:10.1371/journal.pone.0155347.g005
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expression does not appear transiently inhibited by the microenvironment, as removing FL
Tregs from the microenvironment and culturing them for up to 48 hours in vitro does not
result in increased S1P1 expression. This suggests a more permanent expression pattern
Fig 6. FL Tregs, in contrast to NLN Tregs, readily migrate to CXCL13 but not to S1P.CD4 T cells were
isolated by negative selection from FL (n = 6) and NLN (n = 6) samples and were rested overnight. Transwell
chemotaxis was performed as described in the experimental procedures section using 1000 ng/ml CXCL13,
25 ng/ml SDF-1α and 1nM D-erythro-S1P. Cells that migrated were surface stained for CD3, CD4, CD25 and
CD127 and were analyzed by flow cytometry using Accucount beads for quantitation. Assays were done in
duplicates for each sample. Line segments represent mean values for each group. Significance indicated by
asterisks (p < 0.05) determined by paired t-test following log-transformation of variables (5 was added to S1P
to obtain positive values).
doi:10.1371/journal.pone.0155347.g006
Fig 7. FL Treg Infiltration, Localization and Retention. Schematic representation of the various molecules
identified that play a role in the accumulation, localization and nodal retention of FL Tregs. Increased
expression of CXCR5 and CXCL13 would be likely to result in B cell follicle localization and accumulation of
FL Tregs. Also, CXCR5-CXCL13 would function as an autokrine loop to futher retain FL Tregs within the
follicle. Increased secretion of IL-16 by these Tregs would result in further recruitment of additional Tregs.
Lastly, nodal egress of FL Tregs would be inhibited by the decreased expression of S1PR1, additionally
resulting in nodal accumulation of FL Tregs.
doi:10.1371/journal.pone.0155347.g007
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conferred on tumor infiltrating Tregs and consequently, a more terminal differentiation pat-
tern. Further study into mechanisms by which FL Tregs acquire these unique expression pat-
terns that facilitate increased tumor localization as well as retention within the malignant node
would undoubtedly result in additional therapeutic targets.
Our studies further show that FL Tregs express a cytokine/chemokine profile that is unique
compared to NLN Tregs, and likely plays a fundamental role in shaping the FL tumor microen-
vironment. For example, we show that IL-16 is abundantly secreted by FL Tregs compared to
NLN (Fig 5). IL-16 has chemo-attractant activity with preferential recruitment of the Th1 and
Treg subsets.[44] Although FL Tregs produce more IL-16 then do NLN Tregs, NLN Tregs have
more IL-16 transcripts. This discrepancy is likely due to mature IL-16 requiring processing of a
precursor molecule.[45, 46] Finally, we demonstrate that FL Tregs produce CCL-3 and CCL-4,
both of which are chemotactic for CCR5 expressing Tregs and CD4 and CD8 effector cells,
more so than NLN Tregs. Taken together, the different transcriptional profile of FL vs. NLN
Tregs leads to different cytokine and chemokine profiles that have both an autocrine effect on
Tregs as well as possible effects on different immune effector cells.
Not all gene expression data we observe directly correlates with protein levels, as described
for IL-16 above. We have previously shown with flow cytometry that there was no statistically
significant difference in the levels of either CD39 or CD73 protein, on a per cell basis,[11] how-
ever, our data here demonstrates reduction in CD39 (ENTDP1) and CD73 transcripts in FL
Tregs as compared to NLN. This discrepancy has at least two potential explanations: First,
intracellular pools of these proteins may differ between different Tregs while surface expression
remains similar (we only assessed extracellular protein levels by flow). Second, global mRNA
and protein levels do not necessarily correlate.[47–49]
We have previously shown that FL Tregs show greater suppressive capacity then those
derived from NLN or RLN.[10] As shown, FL Tregs express higher levels of IL-10, CTLA-4
and GITR then do NLN Tregs at both transcriptional and protein levels, consistent with this
increased suppressive capacity. This is of particular interest as therapeutic agents targeting
each of these inhibitory pathways are at various stages of development. Additionally, it has
recently been shown that signaling through Treg S1P1 results in an AKT mediated attenuation
of Treg suppression.[50] Because FL Tregs have lower expression of S1P1 then do NLN Tregs,
they may be subjected to less attenuation of their suppressive function resulting in greater
effector T-cell suppression then seen with NLN Tregs.
There is great interest in targeting Tregs therapeutically to augment immunotherapeutic
approaches such as tumor vaccines or checkpoint inhibitors. Because our data suggest that
FL Tregs are skewed towards a TFR phenotype, along with recent findings that suggest Tfh
support FL cell viability (through CD40L expression and elaboration of IL-4),[51] it is possi-
ble that depletion of Tregs in FL could have an adverse clinical effect by removing the
“brakes” on the FL supporting TFH. Furthermore, given cytokines/chemokines elaborated by
FL Tregs, it is likely that Treg depletion would have additional effects on remodeling tumor
microenvironment, which may or may not be clinically beneficial. Understanding how
microenvironment of a given tumor type modulates the function of Tregs infiltrating the
tumor will be critical to determining whether Treg depletion is a rational therapeutic strategy
for a given tumor.
Our data support shaping of the tumor infiltrating Treg transcriptome by the tumor micro-
environment. Further insights into pathways through which tumors modulate the Treg tran-
scriptome and thus the function of tumor infiltrating Tregs could lead to discovery of new
therapeutic targets.
Treg Homing and Retention in Follicular Lymphoma
PLOSONE | DOI:10.1371/journal.pone.0155347 May 26, 2016 14 / 18
Supporting Information
S1 File. Supplemental Methods, Figures and Tables.
(PDF)
S2 File. Supporting Data. File containing data for flow cytometry, Luminex, migration and
S1P1 qPCR assays.
(PDF)
Author Contributions
Conceived and designed the experiments: HN SPHWRB SAQMA SLW SMA SHB. Performed
the experiments: HN SPH SAQ CMBMAMK. Analyzed the data: HN AFR SPH OH SAQ
CMBMA SLW SMAMK SHB. Wrote the paper: HN AFR SPH OHWRB SAQMA SLW
SMAMK SHB.
References
1. Friedberg JW, Taylor MD, Cerhan JR, Flowers CR, Dillon H, Farber CM, et al. Follicular lymphoma in
the United States: first report of the national LymphoCare study. Journal of clinical oncology: official
journal of the American Society of Clinical Oncology. 2009; 27(8):1202–8. doi: 10.1200/JCO.2008.18.
1495 PMID: 19204203; PubMed Central PMCID: PMC2738614.
2. Carreras J, Lopez-Guillermo A, Fox BC, Colomo L, Martinez A, Roncador G, et al. High numbers of
tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in fol-
licular lymphoma. Blood. 2006; 108(9):2957–64. doi: 10.1182/blood-2006-04-018218 PMID:
16825494.
3. Carreras J, Lopez-Guillermo A, Roncador G, Villamor N, Colomo L, Martinez A, et al. High numbers of
tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with
improved overall survival in follicular lymphoma. Journal of clinical oncology: official journal of the Amer-
ican Society of Clinical Oncology. 2009; 27(9):1470–6. doi: 10.1200/JCO.2008.18.0513 PMID:
19224853.
4. Tzankov A, Meier C, Hirschmann P, Went P, Pileri SA, Dirnhofer S. Correlation of high numbers of intra-
tumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell
lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica. 2008; 93(2):193–
200. doi: 10.3324/haematol.11702 PMID: 18223287.
5. Farinha P, Al-Tourah A, Gill K, Klasa R, Connors JM, Gascoyne RD. The architectural pattern of
FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic
transformation. Blood. 2010; 115(2):289–95. doi: 10.1182/blood-2009-07-235598 PMID: 19901260.
6. Sweetenham JW, Goldman B, LeBlanc ML, Cook JR, Tubbs RR, Press OW, et al. Prognostic value of
regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma
treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group
Study. Ann Oncol. 2010; 21(6):1196–202. doi: 10.1093/annonc/mdp460 PMID: 19875761; PubMed
Central PMCID: PMC2875547.
7. Lee AM, Clear AJ, Calaminici M, Davies AJ, Jordan S, MacDougall F, et al. Number of CD4+ cells and
location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays
correlates with outcome. Journal of clinical oncology: official journal of the American Society of Clinical
Oncology. 2006; 24(31):5052–9. doi: 10.1200/JCO.2006.06.4642 PMID: 17033038.
8. Chung Y, Tanaka S, Chu F, Nurieva RI, Martinez GJ, Rawal S, et al. Follicular regulatory T cells
expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nature medicine. 2011; 17(8):983–8.
doi: 10.1038/nm.2426 PMID: 21785430; PubMed Central PMCID: PMC3151340.
9. Nishikawa H, Sakaguchi S. Regulatory T cells in tumor immunity. International journal of cancer Journal
international du cancer. 2010; 127(4):759–67. doi: 10.1002/ijc.25429 PMID: 20518016.
10. Hilchey SP, De A, Rimsza LM, Bankert RB, Bernstein SH. Follicular lymphoma intratumoral CD4
+CD25+GITR+ regulatory T cells potently suppress CD3/CD28-costimulated autologous and alloge-
neic CD8+CD25- and CD4+CD25- T cells. Journal of immunology. 2007; 178(7):4051–61. PMID:
17371959.
11. Hilchey SP, Kobie JJ, Cochran MR, Secor-Socha S, Wang JC, Hyrien O, et al. Human follicular lym-
phoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness. Journal
Treg Homing and Retention in Follicular Lymphoma
PLOSONE | DOI:10.1371/journal.pone.0155347 May 26, 2016 15 / 18
of immunology. 2009; 183(10):6157–66. doi: 10.4049/jimmunol.0900475 PMID: 19864600; PubMed
Central PMCID: PMC2917799.
12. Chen ML, Pittet MJ, Gorelik L, Flavell RA, Weissleder R, von Boehmer H, et al. Regulatory T cells sup-
press tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci U S
A. 2005; 102(2):419–24. doi: 10.1073/pnas.0408197102 PMID: 15623559; PubMed Central PMCID:
PMC544311.
13. Yang ZZ, Novak AJ, Ziesmer SC, Witzig TE, Ansell SM. Attenuation of CD8(+) T-cell function by CD4
(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma. Cancer research. 2006; 66
(20):10145–52. doi: 10.1158/0008-5472.CAN-06-1822 PMID: 17047079; PubMed Central PMCID:
PMC2680600.
14. Yang ZZ, Novak AJ, Stenson MJ, Witzig TE, Ansell SM. Intratumoral CD4+CD25+ regulatory T-cell-
mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood. 2006; 107
(9):3639–46. doi: 10.1182/blood-2005-08-3376 PMID: 16403912; PubMed Central PMCID:
PMC1895773.
15. Gribben JG. Implications of the tumor microenvironment on survival and disease response in follicular
lymphoma. Curr Opin Oncol. 2010; 22(5):424–30. doi: 10.1097/CCO.0b013e32833d5938 PMID:
20679770.
16. Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, ChanWC, et al. Prediction of survival in follic-
ular lymphoma based on molecular features of tumor-infiltrating immune cells. The New England jour-
nal of medicine. 2004; 351(21):2159–69. doi: 10.1056/NEJMoa041869 PMID: 15548776.
17. Wahlin BE, Aggarwal M, Montes-Moreno S, Gonzalez LF, Roncador G, Sanchez-Verde L, et al. A unify-
ing microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1—
positive, regulatory, cytotoxic, and helper T cells and macrophages. Clin Cancer Res. 2010; 16(2):637–
50. doi: 10.1158/1078-0432.CCR-09-2487 PMID: 20068089.
18. Alvaro T, Lejeune M, Salvado MT, Lopez C, Jaen J, Bosch R, et al. Immunohistochemical patterns of
reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients.
Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2006; 24
(34):5350–7. doi: 10.1200/JCO.2006.06.4766 PMID: 17135637.
19. Wang Y, Su MA, Wan YY. An essential role of the transcription factor GATA-3 for the function of regula-
tory T cells. Immunity. 2011; 35(3):337–48. doi: 10.1016/j.immuni.2011.08.012 PMID: 21924928;
PubMed Central PMCID: PMC3182399.
20. Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. The transcription factor
T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nature immunol-
ogy. 2009; 10(6):595–602. doi: 10.1038/ni.1731 PMID: 19412181; PubMed Central PMCID:
PMC2712126.
21. Stock P, Akbari O, Berry G, Freeman GJ, Dekruyff RH, Umetsu DT. Induction of T helper type 1-like
regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nature immunology.
2004; 5(11):1149–56. doi: 10.1038/ni1122 PMID: 15448689.
22. Ame-Thomas P, Le Priol J, Yssel H, Caron G, Pangault C, Jean R, et al. Characterization of intratu-
moral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells. Leukemia.
2012; 26(5):1053–63. doi: 10.1038/leu.2011.301 PMID: 22015774; PubMed Central PMCID:
PMC3428269.
23. Hilchey SP, Rosenberg AF, Hyrien O, Secor-Socha S, Cochran MR, Brady MT, et al. Follicular lym-
phoma tumor-infiltrating T-helper (T(H)) cells have the same polyfunctional potential as normal nodal T
(H) cells despite skewed differentiation. Blood. 2011; 118(13):3591–602. doi: 10.1182/blood-2011-03-
340646 PMID: 21821704; PubMed Central PMCID: PMC3186335.
24. Wollenberg I, Agua-Doce A, Hernandez A, Almeida C, Oliveira VG, Faro J, et al. Regulation of the ger-
minal center reaction by Foxp3+ follicular regulatory T cells. Journal of immunology. 2011; 187
(9):4553–60. doi: 10.4049/jimmunol.1101328 PMID: 21984700.
25. Linterman MA, PiersonW, Lee SK, Kallies A, Kawamoto S, Rayner TF, et al. Foxp3+ follicular regula-
tory T cells control the germinal center response. Nature medicine. 2011; 17(8):975–82. doi: 10.1038/
nm.2425 PMID: 21785433; PubMed Central PMCID: PMC3182542.
26. Brady MT, Hilchey SP, Hyrien O, Spence SA, Bernstein SH. Mesenchymal stromal cells support the
viability and differentiation of follicular lymphoma-infiltrating follicular helper T-cells. PloS one. 2014; 9
(5):e97597. doi: 10.1371/journal.pone.0097597 PMID: 24836297; PubMed Central PMCID:
PMC4023957.
27. Cha Z, Zang Y, Guo H, Rechlic JR, Olasnova LM, Gu H, et al. Association of peripheral CD4+ CXCR5+
T cells with chronic lymphocytic leukemia. Tumour Biol. 2013; 34(6):3579–85. doi: 10.1007/s13277-
013-0937-2 PMID: 23807677.
Treg Homing and Retention in Follicular Lymphoma
PLOSONE | DOI:10.1371/journal.pone.0155347 May 26, 2016 16 / 18
28. Gu-Trantien C, Loi S, Garaud S, Equeter C, Libin M, deWind A, et al. CD4(+) follicular helper T cell infil-
tration predicts breast cancer survival. J Clin Invest. 2013; 123(7):2873–92. doi: 10.1172/JCI67428
PMID: 23778140; PubMed Central PMCID: PMC3696556.
29. Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, et al. Spatiotemporal dynamics
of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013; 39
(4):782–95. doi: 10.1016/j.immuni.2013.10.003 PMID: 24138885.
30. Shi W, Li X, Cha Z, Sun S, Wang L, Jiao S, et al. Dysregulation of circulating follicular helper T cells in
nonsmall cell lung cancer. DNA Cell Biol. 2014; 33(6):355–60. doi: 10.1089/dna.2013.2332 PMID:
24593033.
31. Jia Y, Zeng Z, Li Y, Li Z, Jin L, Zhang Z, et al. Impaired function of CD4+ T follicular helper (Tfh) cells
associated with hepatocellular carcinoma progression. PloS one. 2015; 10(2):e0117458. doi: 10.1371/
journal.pone.0117458 PMID: 25689070; PubMed Central PMCID: PMC4331507.
32. Hilchey SP, Bernstein SH. Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and
CD8+ T-cell proliferation within unseparated mononuclear cells frommalignant and non-malignant
human lymph node biopsies. Immunol Invest. 2007; 36(5–6):629–48. doi: 10.1080/
08820130701674463 PMID: 18161522.
33. Ayyoub M, Deknuydt F, Raimbaud I, Dousset C, Leveque L, Bioley G, et al. Humanmemory FOXP3+
Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor
RORgamma t. Proc Natl Acad Sci U S A. 2009; 106(21):8635–40. doi: 10.1073/pnas.0900621106
PMID: 19439651; PubMed Central PMCID: PMC2688993.
34. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role
in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. The Journal of
experimental medicine. 2000; 192(2):295–302. PMID: 10899916; PubMed Central PMCID:
PMC2193261.
35. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, et al. Immunologic self-toler-
ance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lympho-
cyte-associated antigen 4. The Journal of experimental medicine. 2000; 192(2):303–10. PMID:
10899917; PubMed Central PMCID: PMC2193248.
36. McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, Collins M, et al. CD4(+)CD25(+)
immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-
induced TNF receptor. Immunity. 2002; 16(2):311–23. PMID: 11869690.
37. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory
T cells through GITR breaks immunological self-tolerance. Nature immunology. 2002; 3(2):135–42.
doi: 10.1038/ni759 PMID: 11812990.
38. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, et al. CTLA-4 control over
Foxp3+ regulatory T cell function. Science. 2008; 322(5899):271–5. doi: 10.1126/science.1160062
PMID: 18845758.
39. Sun L, Yi S, O'Connell PJ. IL-10 is required for human CD4(+)CD25(+) regulatory T cell-mediated sup-
pression of xenogeneic proliferation. Immunol Cell Biol. 2010; 88(4):477–85. doi: 10.1038/icb.2009.117
PMID: 20177412.
40. Strauss L, Bergmann C, Szczepanski M, Gooding W, Johnson JT, Whiteside TL. A unique subset of
CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates
suppression in the tumor microenvironment. Clin Cancer Res. 2007; 13(15 Pt 1):4345–54. doi: 10.
1158/1078-0432.CCR-07-0472 PMID: 17671115.
41. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-
secreting type 1 regulatory T cells in rodents and humans. Immunol Rev. 2006; 212:28–50. doi: 10.
1111/j.0105-2896.2006.00420.x PMID: 16903904.
42. Cyster JG, Schwab SR. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs.
Annu Rev Immunol. 2012; 30:69–94. doi: 10.1146/annurev-immunol-020711-075011 PMID:
22149932.
43. Priceman SJ, Shen S, Wang L, Deng J, Yue C, Kujawski M, et al. S1PR1 is crucial for accumulation of
regulatory T cells in tumors via STAT3. Cell reports. 2014; 6(6):992–9. doi: 10.1016/j.celrep.2014.02.
016 PMID: 24630990; PubMed Central PMCID: PMC3988983.
44. McFadden C, Morgan R, Rahangdale S, Green D, Yamasaki H, Center D, et al. Preferential migration
of T regulatory cells induced by IL-16. Journal of immunology. 2007; 179(10):6439–45. PMID:
17982032.
45. Zhang Y, Kornfeld H, Cruikshank WW, Kim S, Reardon CC, Center DM. Nuclear translocation of the N-
terminal prodomain of interleukin-16. J Biol Chem. 2001; 276(2):1299–303. doi: 10.1074/jbc.
M008513200 PMID: 11032842.
Treg Homing and Retention in Follicular Lymphoma
PLOSONE | DOI:10.1371/journal.pone.0155347 May 26, 2016 17 / 18
46. Zhang Y, Center DM, Wu DM, CruikshankWW, Yuan J, Andrews DW, et al. Processing and activation
of pro-interleukin-16 by caspase-3. J Biol Chem. 1998; 273(2):1144–9. PMID: 9422780.
47. Taquet N, Dumont S, Vonesch JL, Hentsch D, Reimund JM, Muller CD. Differential between protein
and mRNA expression of CCR7 and SSTR5 receptors in Crohn's disease patients. Mediators Inflamm.
2009; 2009:285812. doi: 10.1155/2009/285812 PMID: 20150960; PubMed Central PMCID:
PMC2817506.
48. Sarro SM, Unruh TL, Zuccolo J, Sanyal R, Luider JM, Auer-Grzesiak IA, et al. Quantification of CD20
mRNA and protein levels in chronic lymphocytic leukemia suggests a post-transcriptional defect. Leuk
Res. 2010; 34(12):1670–3. doi: 10.1016/j.leukres.2010.06.031 PMID: 20674973.
49. Shebl FM, Pinto LA, Garcia-Pineres A, Lempicki R, Williams M, Harro C, et al. Comparison of mRNA
and protein measures of cytokines following vaccination with human papillomavirus-16 L1 virus-like
particles. Cancer Epidemiol Biomarkers Prev. 2010; 19(4):978–81. doi: 10.1158/1055-9965.EPI-10-
0064 PMID: 20332253; PubMed Central PMCID: PMC2852493.
50. Liu G, Burns S, Huang G, Boyd K, Proia RL, Flavell RA, et al. The receptor S1P1 overrides regulatory T
cell-mediated immune suppression through Akt-mTOR. Nature immunology. 2009; 10(7):769–77. doi:
10.1038/ni.1743 PMID: 19483717; PubMed Central PMCID: PMC2732340.
51. Rawal S, Chu F, Zhang M, Park HJ, Nattamai D, Kannan S, et al. Cross talk between follicular Th cells
and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenviron-
ment. Journal of immunology. 2013; 190(12):6681–93. doi: 10.4049/jimmunol.1201363 PMID:
23686488; PubMed Central PMCID: PMC3680117.
Treg Homing and Retention in Follicular Lymphoma
PLOSONE | DOI:10.1371/journal.pone.0155347 May 26, 2016 18 / 18
